F0050
5q Deletion and Monosomy / Numerical Abnormalities
Test Details: Del(5q) is among the most extensively studied cytogenetic abnormalities in Myelodysplastic syndrome (MDS). Involvement of chromosome 5 is found in 40% of therapy-related myeloid disorders. Fluorescence in situ hybridization (FISH) complements conventional karyotyping by the ability to evaluate large numbers of both interphase and metaphase nuclei. This has an important diagnostic and prognostic role which affects the choice of therapies. 5q deletion in MDS is considered as a favourable prognosis.
![](assets/img/diagnleftimg.png)
Category
Cytogenetics
Pre-test Information
Clinical history, CBC report and treatment status of the patient is mandatory.
Report Delivery
3 working days
Gender
All
Organ
Blood / Bone Marrow
5q Deletion and Monosomy / Numerical Abnormalities
3000
Most Searched Diagnostic Tests